Obesity and Metabolic Syndrome: Risk Factors, Health Impacts, and Prevention Strategies
Main Article Content
Abstract
Obesity and metabolic syndrome are major public health issues, marked by increasing prevalence and significant negative impacts on health. This study aims to analyze the associated risk factors, health consequences, and effective prevention strategies. The findings indicate that poor dietary habits, increased sedentary behavior, and economic barriers are the main contributing factors to these conditions. Obesity and metabolic syndrome significantly raise the risks of cardiovascular diseases, type 2 diabetes, and other chronic illnesses.
Current strategies, such as nutritional awareness campaigns and taxes on sugary products, have shown positive outcomes, but their overall impact remains limited, especially among vulnerable populations. Multidimensional approaches, including the promotion of physical activity, dietary consultations, and strong public policies appear to be the most effective. However, implementing these strategies requires better intersectoral coordination, increased resources, and enhanced public awareness.
In conclusion, preventing obesity and metabolic syndrome requires collective initiatives and the integration of individual, community-based, and policy-level solutions. Such an approach will help reduce their prevalence, improve individuals’ quality of life, and lessen the strain on healthcare systems.
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
• AS Bleich, S. N., Vercammen, K. A., Koma, J. W., & Li, Z. (2022). Trends in beverage consumption among children and adults in the United States. Obesity, 28(2), 120-129.
• Canada Santé Publique. (2021). Prévalence du syndrome métabolique et facteurs associés au Canada. Ottawa, Canada. Disponible sur : https://www.canada.ca
• Grundy, S. M., Cleeman, J. I., Daniels, S. R., et al. (2020). Diagnosis and management of the metabolic syndrome. Circulation, 112(17), 2735-2752.
• HUG(Hêpitaux Universitaires Genève).(2023).ELIPS pour combattre l’infarctus et l’athérosclérose. Syndrome metabolique. Disponible sur : www.hug.ch elips, Syndrome-metabolique
• INSERM (Institut national de la santé et de la recherche médicale). (2021). Syndrome métabolique et santé publique : Prévalence et facteurs de risque. Paris, France. Disponible sur : https://www.inserm.fr
• Johnson, R. J., Nakagawa, T., Sanchez-Lozada, L. G., et al. (2020). Sugar, Uric Acid, and the Etiology of Diabetes and Obesity. Diabètes, 57(11), 2746-2752.
• Le Monde. (2024). Contre l'obésité et le diabète : L'importance d'une approche nutritionnelle. Disponible sur : https://www.lemonde.fr
• Monteiro, C. A., Moubarac, J.-C., Cannon, G., Ng, S. W., & Popkin, B. (2019). Ultra-processed products are becoming dominant in the global food system. Obesity Reviews, 20(S2), 12-25.
• Observatoire de la prévention. (2021). Stratégies pour prévenir le syndrome métabolique. Montréal, Canada. Disponible sur : https://www.observatoireprevention.org
• Organisation mondiale de la santé (OMS). (2022). Rapport mondial sur l’obésité et le syndrome métabolique. Genève, Suisse. Disponible sur : https://www.who.int
• PMC (PubMed Central). (2021). Impact of physical activity on metabolic syndrome management. Disponible sur : https://www.ncbi.nlm.nih.gov/pmc
• Swinburn, B. A., Kraak, V. I., Allender, S., et al. (2020). The global obesity pandemic: Shaped by global drivers and local environments. The Lancet, 378(9793), 804-814.
• Wadden, T. A., Brownell, K. D., & Foster, G. D. (2019). Obesity: Responding to the global epidemic. Journal of Consulting and Clinical Psychology, 74(4), 597-605.